Health Canada to keep importing Kaleo’s epinephrine shot amid shortages

Share this post

The Canadian health regulator said on Friday it would keep importing U.S.-based Kaleo Inc’s epinephrine auto-injectors and expects adequate supply of the devices in the country over the coming months.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply